A3/Kawakami
Resource Report
Resource Website
|
RRID:CVCL_1062
|
Homo sapiens (Human)
|
Diffuse large B-cell lymphoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2144611
PMID:2985879
PMID:3159941
PMID:3874327
PMID:6601597
PMID:9290701
PMID:9510473
PMID:10739008
PMID:11226526
PMID:20164919
PMID:22460905
PMID:25355872
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:30285677
PMID:30894373
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Female |
A3/KAW, A3-KAW, A3KAW, A3/Kawa |
|
|
CLO:CLO_0037046,
EFO:EFO_0006532,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03470896,
BioSample:SAMN10987848,
cancercelllines:CVCL_1062,
Cell_Model_Passport:SIDM00495,
ChEMBL-Cells:CHEMBL3308225,
ChEMBL-Targets:CHEMBL2366273,
Cosmic:910935,
Cosmic:919153,
Cosmic-CLP:910935,
DepMap:ACH-000697,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:910935,
GEO:GSM886855,
GEO:GSM887920,
GEO:GSM1669584,
IARC_TP53:183,
IARC_TP53:21162,
JCRB:JCRB0101,
LiGeA:CCLE_380,
LINCS_LDP:LCL-1149,
PharmacoDB:A3KAW_41_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1062,
PubChem_Cell_line:CVCL_1062,
Wikidata:Q54606737 |
|
|
CVCL_1062 |
2026-08-29 05:19:43 |
0 |
23132/87
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1046
|
Homo sapiens (Human)
|
Gastric adenocarcinoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8100658
PMID:11668190
PMID:20164919
PMID:20215515
PMID:22460905
PMID:24807215
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:30894373
PMID:30971826
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Male |
23132-87, 2313287, St 23132, St23132, 23132 |
|
|
CLO:CLO_0001202,
EFO:EFO_0006528,
CLDB:cl38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:822,
BioSample:SAMN03470944,
BioSample:SAMN03473375,
BioSample:SAMN10988573,
cancercelllines:CVCL_1046,
Cell_Model_Passport:SIDM00980,
ChEMBL-Cells:CHEMBL3308702,
ChEMBL-Targets:CHEMBL1075382,
Cosmic:910924,
Cosmic:1995324,
Cosmic:2484956,
Cosmic-CLP:910924,
DepMap:ACH-000948,
DSMZ:ACC-201,
DSMZCellDive:ACC-201,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:910924,
GEO:GSM827572,
GEO:GSM886838,
GEO:GSM887901,
GEO:GSM1374371,
GEO:GSM1374372,
GEO:GSM1669566,
IARC_TP53:21150,
LiGeA:CCLE_415,
LINCS_LDP:LCL-1532,
PharmacoDB:2313287_13_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1046,
PubChem_Cell_line:CVCL_1046,
Wikidata:Q54583395 |
|
|
CVCL_1046 |
2026-08-29 05:18:42 |
2 |
253J-BV
Resource Report
Resource Website
|
KCLB Cat# 80002, RRID:CVCL_7937
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Characteristics: Metastatic phenotype. Obtained after 5 serial passages of the parent cell line in the bladder of nude mice., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: BLA-40 bladder carcinoma cell line panel.
|
PMID:7658585
PMID:26589293
PMID:29732388
PMID:31068700
|
Cancer cell line
|
Male |
253JB-V, 253J B-V, 253JBV, 253J-Bladder-V |
KCLB |
80002 |
BTO:BTO_0004894,
EFO:EFO_0022648,
ArrayExpress:E-MTAB-2770,
BioSample:SAMN10987963,
cancercelllines:CVCL_7937,
Cell_Model_Passport:SIDM01624,
Cosmic:846282,
Cosmic:1082645,
Cosmic:1938695,
DepMap:ACH-000026,
GEO:GSM136239,
IARC_TP53:30015,
KCLB:80002,
LiGeA:CCLE_144,
PharmacoDB:253JBV_15_2019,
Wikidata:Q54583655 |
cvcl_7935 |
|
CVCL_7937 |
2026-08-29 05:18:44 |
0 |
253J-BV
Resource Report
Resource Website
|
RRID:CVCL_7937
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Characteristics: Metastatic phenotype. Obtained after 5 serial passages of the parent cell line in the bladder of nude mice., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: BLA-40 bladder carcinoma cell line panel.
|
PMID:7658585
PMID:26589293
PMID:29732388
PMID:31068700
|
Cancer cell line
|
Male |
253JB-V, 253J B-V, 253JBV, 253J-Bladder-V |
|
|
BTO:BTO_0004894,
EFO:EFO_0022648,
ArrayExpress:E-MTAB-2770,
BioSample:SAMN10987963,
cancercelllines:CVCL_7937,
Cell_Model_Passport:SIDM01624,
Cosmic:846282,
Cosmic:1082645,
Cosmic:1938695,
DepMap:ACH-000026,
GEO:GSM136239,
IARC_TP53:30015,
KCLB:80002,
LiGeA:CCLE_144,
PharmacoDB:253JBV_15_2019,
Wikidata:Q54583655 |
cvcl_7935 |
|
CVCL_7937 |
2026-08-29 05:18:44 |
0 |
253J
Resource Report
Resource Website
1+ mentions
Discontinued
|
ATCC Cat# HTB-108, RRID:CVCL_7935
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Population: Caucasian., Part of: UBC-40 urothelial bladder cancer cell line index., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: BLA-40 bladder carcinoma cell line panel.
|
PMID:66978
PMID:327080
PMID:571047
PMID:748774
PMID:944089
PMID:3518877
PMID:3708594
PMID:4431054
PMID:6244232
PMID:6582512
PMID:6935474
PMID:7459858
PMID:7658585
PMID:8873383
PMID:11207054
PMID:11416159
PMID:11921286
PMID:12127398
PMID:15846775
PMID:16885334
PMID:23401075
PMID:24035680
PMID:24367658
PMID:25997541
PMID:26589293
PMID:26621286
PMID:27270441
PMID:29732388
PMID:31068700
|
Cancer cell line
|
Male |
253j, 253-J, 253 J, 253J-P, 253J-Parental, 253J P, 253JP |
ATCC |
HTB-108 |
BTO:BTO_0004796,
ArrayExpress:E-MTAB-2770,
ATCC:HTB-108,
BioSample:SAMN10987961,
cancercelllines:CVCL_7935,
Cell_Model_Passport:SIDM01529,
Cosmic:715794,
Cosmic:760476,
Cosmic:845564,
Cosmic:925827,
Cosmic:928820,
Cosmic:1016884,
Cosmic:1046680,
Cosmic:1082644,
Cosmic:1285102,
Cosmic:1285997,
Cosmic:1927305,
Cosmic:1938694,
Cosmic:2050426,
Cosmic:2057433,
Cosmic:2444255,
Cosmic:2685929,
Cosmic:2700994,
DepMap:ACH-000011,
GEO:GSM136240,
GEO:GSM1574546,
GEO:GSM1574574,
IARC_TP53:21034,
KCLB:80001,
LiGeA:CCLE_259,
PharmacoDB:253J_14_2019,
Wikidata:Q54583653 |
|
|
CVCL_7935 |
2026-08-29 05:18:44 |
5 |
ACHN
Resource Report
Resource Website
1000+ mentions
Discontinued
Discontinued
|
RRID:CVCL_1067
|
Homo sapiens (Human)
|
Papillary renal cell carcinoma
|
Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: JFCR39 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2041050
PMID:7591954
PMID:8620516
PMID:9331090
PMID:10074909
PMID:10700174
PMID:10929426
PMID:11146448
PMID:11414198
PMID:15748285
PMID:17088437
PMID:17409424
PMID:19372543
PMID:20164919
PMID:20215515
PMID:22068913
PMID:22336246
PMID:22347499
PMID:22384151
PMID:22460905
PMID:22628656
PMID:22949125
PMID:23856246
PMID:23933261
PMID:24279929
PMID:24477694
PMID:24670534
PMID:25485619
PMID:25877200
PMID:25984343
PMID:26589293
PMID:26972028
PMID:27141528
PMID:27377824
PMID:27397505
PMID:27807467
PMID:27993170
PMID:28196595
PMID:28489074
PMID:30894373
PMID:31068700
PMID:31733513
PMID:35839778
PMID:38861359
|
Cancer cell line
|
Male |
|
|
|
BTO:BTO_0003846,
CLO:CLO_0001654,
EFO:EFO_0002108,
CLDB:cl236,
CLDB:cl237,
CLDB:cl4951,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-1611,
BioSample:SAMN01821536,
BioSample:SAMN03473205,
BioSample:SAMN10988309,
cancercelllines:CVCL_1067,
CCRID:1101HUM-PUMC000334,
CCRID:3101HUMSCSP5063,
CCRID:3101HUMTCHu199,
CCRID:4201HUM-CCTCC00102,
CCTCC:GDC0102,
Cell_Model_Passport:SIDM00123,
ChEMBL-Cells:CHEMBL3307633,
ChEMBL-Targets:CHEMBL614519,
CLS:300117,
Cosmic:687939,
Cosmic:849382,
Cosmic:875873,
Cosmic:877456,
Cosmic:897462,
Cosmic:905950,
Cosmic:974302,
Cosmic:979708,
Cosmic:982275,
Cosmic:1044260,
Cosmic:1092592,
Cosmic:1152534,
Cosmic:1175850,
Cosmic:1305374,
Cosmic:1312362,
Cosmic:1436045,
Cosmic:1998434,
Cosmic:2520631,
Cosmic-CLP:905950,
DepMap:ACH-000046,
ECACC:88100508,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
ENCODE:ENCBS569UYK,
ENCODE:ENCBS897ZFQ,
ENCODE:ENCBS972GIY,
GDSC:905950,
GEO:GSM2093,
GEO:GSM50228,
GEO:GSM50292,
GEO:GSM743482,
GEO:GSM750837,
GEO:GSM799373,
GEO:GSM799436,
GEO:GSM846286,
GEO:GSM886863,
GEO:GSM887928,
GEO:GSM1153446,
GEO:GSM1181298,
GEO:GSM1181324,
GEO:GSM1669593,
GEO:GSM2124661,
IARC_TP53:21039,
IBRC:C10105,
ICLC:HTL99007,
IGRhCellID:ACHN,
IZSLER:BS TCL 68,
KCB:KCB 200611YJ,
KCLB:21611,
LiGeA:CCLE_085,
LINCS_LDP:LCL-1756,
Lonza:1467,
NCBI_Iran:C206,
NCI-DTP:ACHN,
PharmacoDB:ACHN_54_2019,
PRIDE:PXD001962,
PRIDE:PXD003105,
PRIDE:PXD003539,
PRIDE:PXD005942,
PRIDE:PXD005946,
PRIDE:PXD030304,
Progenetix:CVCL_1067,
PubChem_Cell_line:CVCL_1067,
RCB:RCB1962,
SKY/M-FISH/CGH:2789,
TKG:TKG 0578,
Ubigene:YC-C087,
Wikidata:Q54608371 |
|
|
CVCL_1067 |
2026-08-29 05:20:44 |
1057 |
ABC-1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1066
|
Homo sapiens (Human)
|
Lung adenocarcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8286010
PMID:9290701
PMID:10358721
PMID:10536175
PMID:11005564
PMID:14581340
PMID:15185009
PMID:15746151
PMID:15999539
PMID:16105816
PMID:19472407
PMID:20164919
PMID:20215515
PMID:20557307
PMID:22460905
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:30894373
PMID:31068700
PMID:31978347
PMID:35839778
|
Cancer cell line
|
Male |
ABC1 |
|
|
CLO:CLO_0001641,
EFO:EFO_0002813,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:504,
BioSample:SAMN03471587,
BioSample:SAMN10988302,
cancercelllines:CVCL_1066,
Cell_Model_Passport:SIDM00494,
CGH-DB:203-1,
CGH-DB:9165-4,
ChEMBL-Cells:CHEMBL3308707,
ChEMBL-Targets:CHEMBL1075391,
Cosmic:801582,
Cosmic:876153,
Cosmic:906791,
Cosmic:917991,
Cosmic:946050,
Cosmic:1066158,
Cosmic:1154598,
Cosmic:1239868,
Cosmic:1571728,
Cosmic:2125217,
Cosmic:2668323,
Cosmic-CLP:906791,
DepMap:ACH-000528,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:EGAS00001002554,
GDSC:906791,
GEO:GSM274670,
GEO:GSM784267,
GEO:GSM827573,
GEO:GSM886861,
GEO:GSM887926,
GEO:GSM1669592,
IARC_TP53:11875,
JCRB:JCRB0815,
LiGeA:CCLE_411,
LINCS_LDP:LCL-1634,
PharmacoDB:ABC1_51_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1066,
PubChem_Cell_line:CVCL_1066,
Wikidata:Q54607712 |
|
|
CVCL_1066 |
2026-08-29 05:19:50 |
2 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
Ubigene Cat# YC-A012, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569
PMID:1246620
PMID:1522048
PMID:2983228
PMID:2990217
PMID:3028716
PMID:3180844
PMID:3371749
PMID:3518877
PMID:4942173
PMID:5668122
PMID:6256643
PMID:6358339
PMID:6401685
PMID:6825208
PMID:6935474
PMID:8380785
PMID:9892199
PMID:10423141
PMID:11416159
PMID:11668190
PMID:12001993
PMID:12661003
PMID:12793746
PMID:13052828
PMID:13207312
PMID:13261081
PMID:14031339
PMID:14185313
PMID:15302935
PMID:15531914
PMID:15901131
PMID:16589695
PMID:16957166
PMID:17311676
PMID:19450234
PMID:19722756
PMID:19941903
PMID:21269460
PMID:21937730
PMID:22068331
PMID:22278370
PMID:22412903
PMID:23205564
PMID:23336012
PMID:23925224
PMID:23925245
PMID:24134916
PMID:24618588
PMID:24696503
PMID:24908793
PMID:25485619
PMID:25807930
PMID:25877200
PMID:25894527
PMID:25960936
PMID:26554430
PMID:26589293
PMID:27397505
PMID:28078501
PMID:28196595
PMID:28261610
PMID:28601559
PMID:29156801
PMID:30175587
PMID:30778230
PMID:30787054
PMID:30894373
PMID:31068700
PMID:31433507
PMID:31790455
PMID:33389257
PMID:35198691
PMID:35839778
PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
Ubigene |
YC-A012 |
BTO:BTO_0000567,
CLO:CLO_0003684,
CLO:CLO_0050910,
EFO:EFO_0001185,
MCCL:MCC:0000219,
CLDB:cl1594,
CLDB:cl1595,
CLDB:cl1596,
CLDB:cl1597,
CLDB:cl1599,
CLDB:cl1600,
CLDB:cl1601,
CLDB:cl1603,
Abcam:ab255448,
Abcam:ab255928,
Abcam:ab260075,
Abcam:ab271142,
Abcam:ab275466,
AddexBio:C0008001/44,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:CCL-2,
ATCC:CRL-7923,
ATCC:CRM-CCL-2,
BCRC:60005,
BCRJ:0100,
BEI_Resources:ARP-153,
BioGRID_ORCS_Cell_line:95,
BioSample:SAMN03471148,
BioSample:SAMN03472333,
BioSample:SAMN10989629,
cancercelllines:CVCL_0030,
CCLV:CCLV-RIE 0082,
CCRID:1101HUM-PUMC000011,
CCRID:1101HUM-PUMC000332,
CCRID:1102HUM-NIFDC00057,
CCRID:3101HUMSCSP504,
CCRID:3101HUMTCHu187,
CCRID:4201HUM-CCTCC00009,
CCRID:5301HUM-KCB90024YJ,
CCTCC:GDC0009,
Cell_Model_Passport:SIDM00846,
ChEMBL-Cells:CHEMBL3308376,
ChEMBL-Targets:CHEMBL399,
CLS:300194,
Cosmic:760219,
Cosmic:760490,
Cosmic:801357,
Cosmic:809231,
Cosmic:877477,
Cosmic:911999,
Cosmic:925354,
Cosmic:928907,
Cosmic:944113,
Cosmic:1019309,
Cosmic:1057766,
Cosmic:1071911,
Cosmic:1131525,
Cosmic:1193029,
Cosmic:1201779,
Cosmic:1324208,
Cosmic:1336880,
Cosmic:1571796,
Cosmic:2301539,
Cosmic:2660190,
Cosmic:2750874,
Cosmic:2791019,
Cosmic:2816214,
Cosmic-CLP:1298134,
dbGAP:phs000640.v4.p1,
DepMap:ACH-001086,
DSMZ:ACC-57,
DSMZCellDive:ACC-57,
ECACC:93021013,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:phs000640,
FCS-free:44-2-47-1-8-9,
GDSC:1298134,
GEO:GSM113863,
GEO:GSM226739,
GEO:GSM226875,
GEO:GSM253298,
GEO:GSM436128,
GEO:GSM436129,
GEO:GSM501788,
GEO:GSM722574,
GEO:GSM722575,
GEO:GSM723055,
GEO:GSM723056,
GEO:GSM1088663,
GEO:GSM1088664,
GEO:GSM1088665,
GEO:GSM1088666,
GEO:GSM1374528,
GEO:GSM1669875,
GEO:GSM1881473,
GEO:GSM1881474,
GEO:GSM1881475,
GEO:GSM7701367,
GEO:GSM7701368,
Hysigen:TCH-C193,
ICLC:HTL95023,
IGRhCellID:HeLA,
IZSLER:BS TCL 20,
JCRB:JCRB9004,
KCB:KCB 86019YJ,
KCB:KCB 90024YJ,
KCLB:10002,
LINCS_HMS:50061,
LINCS_LDP:LCL-1512,
Lonza:51,
MeSH:D006367,
NCBI_Iran:C115,
PharmacoDB:HeLa_536_2019,
PRIDE:PRD000007,
PRIDE:PRD000032,
PRIDE:PRD000123,
PRIDE:PRD000124,
PRIDE:PRD000345,
PRIDE:PRD000376,
PRIDE:PRD000525,
PRIDE:PRD000526,
PRIDE:PRD000527,
PRIDE:PXD000013,
PRIDE:PXD000243,
PRIDE:PXD000252,
PRIDE:PXD000279,
PRIDE:PXD000396,
PRIDE:PXD000474,
PRIDE:PXD000589,
PRIDE:PXD000661,
PRIDE:PXD000680,
PRIDE:PXD000759,
PRIDE:PXD000883,
PRIDE:PXD000895,
PRIDE:PXD000900,
PRIDE:PXD000953,
PRIDE:PXD000954,
PRIDE:PXD000999,
PRIDE:PXD001047,
PRIDE:PXD001118,
PRIDE:PXD001154,
PRIDE:PXD001175,
PRIDE:PXD001249,
PRIDE:PXD001258,
PRIDE:PXD001259,
PRIDE:PXD001278,
PRIDE:PXD001305,
PRIDE:PXD001374,
PRIDE:PXD001381,
PRIDE:PXD001396,
PRIDE:PXD001441,
PRIDE:PXD001541,
PRIDE:PXD001548,
PRIDE:PXD001574,
PRIDE:PXD001660,
PRIDE:PXD001781,
PRIDE:PXD001798,
PRIDE:PXD001805,
PRIDE:PXD001806,
PRIDE:PXD001810,
PRIDE:PXD001863,
PRIDE:PXD001907,
PRIDE:PXD002001,
PRIDE:PXD002039,
PRIDE:PXD002066,
PRIDE:PXD002252,
PRIDE:PXD002277,
PRIDE:PXD002378,
PRIDE:PXD002383,
PRIDE:PXD002395,
PRIDE:PXD002572,
PRIDE:PXD002591,
PRIDE:PXD002704,
PRIDE:PXD002844,
PRIDE:PXD002880,
PRIDE:PXD003186,
PRIDE:PXD003209,
PRIDE:PXD003258,
PRIDE:PXD003370,
PRIDE:PXD003503,
PRIDE:PXD003530,
PRIDE:PXD003560,
PRIDE:PXD003792,
PRIDE:PXD003813,
PRIDE:PXD003909,
PRIDE:PXD003913,
PRIDE:PXD003917,
PRIDE:PXD003924,
PRIDE:PXD004182,
PRIDE:PXD004271,
PRIDE:PXD004273,
PRIDE:PXD004452,
PRIDE:PXD004613,
PRIDE:PXD004736,
PRIDE:PXD004900,
PRIDE:PXD004914,
PRIDE:PXD004933,
PRIDE:PXD004934,
PRIDE:PXD004940,
PRIDE:PXD004995,
PRIDE:PXD005018,
PRIDE:PXD005107,
PRIDE:PXD005181,
PRIDE:PXD005346,
PRIDE:PXD005349,
PRIDE:PXD005366,
PRIDE:PXD005466,
PRIDE:PXD005509,
PRIDE:PXD005572,
PRIDE:PXD005712,
PRIDE:PXD005955,
PRIDE:PXD006112,
PRIDE:PXD006293,
PRIDE:PXD012045,
PRIDE:PXD012188,
PRIDE:PXD013064,
PRIDE:PXD023271,
PRIDE:PXD023835,
PRIDE:PXD027504,
PRIDE:PXD029773,
PRIDE:PXD030304,
Progenetix:CVCL_0030,
PubChem_Cell_line:CVCL_0030,
RCB:RCB0007,
RCB:RCB3680,
SKY/M-FISH/CGH:5351,
TKG:TKG 0331,
TOKU-E:1434,
Ubigene:YC-A012,
Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-08-29 05:16:08 |
39236 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
BEI_Resources Cat# ARP-153, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569
PMID:1246620
PMID:1522048
PMID:2983228
PMID:2990217
PMID:3028716
PMID:3180844
PMID:3371749
PMID:3518877
PMID:4942173
PMID:5668122
PMID:6256643
PMID:6358339
PMID:6401685
PMID:6825208
PMID:6935474
PMID:8380785
PMID:9892199
PMID:10423141
PMID:11416159
PMID:11668190
PMID:12001993
PMID:12661003
PMID:12793746
PMID:13052828
PMID:13207312
PMID:13261081
PMID:14031339
PMID:14185313
PMID:15302935
PMID:15531914
PMID:15901131
PMID:16589695
PMID:16957166
PMID:17311676
PMID:19450234
PMID:19722756
PMID:19941903
PMID:21269460
PMID:21937730
PMID:22068331
PMID:22278370
PMID:22412903
PMID:23205564
PMID:23336012
PMID:23925224
PMID:23925245
PMID:24134916
PMID:24618588
PMID:24696503
PMID:24908793
PMID:25485619
PMID:25807930
PMID:25877200
PMID:25894527
PMID:25960936
PMID:26554430
PMID:26589293
PMID:27397505
PMID:28078501
PMID:28196595
PMID:28261610
PMID:28601559
PMID:29156801
PMID:30175587
PMID:30778230
PMID:30787054
PMID:30894373
PMID:31068700
PMID:31433507
PMID:31790455
PMID:33389257
PMID:35198691
PMID:35839778
PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
BEI_Resources |
ARP-153 |
BTO:BTO_0000567,
CLO:CLO_0003684,
CLO:CLO_0050910,
EFO:EFO_0001185,
MCCL:MCC:0000219,
CLDB:cl1594,
CLDB:cl1595,
CLDB:cl1596,
CLDB:cl1597,
CLDB:cl1599,
CLDB:cl1600,
CLDB:cl1601,
CLDB:cl1603,
Abcam:ab255448,
Abcam:ab255928,
Abcam:ab260075,
Abcam:ab271142,
Abcam:ab275466,
AddexBio:C0008001/44,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:CCL-2,
ATCC:CRL-7923,
ATCC:CRM-CCL-2,
BCRC:60005,
BCRJ:0100,
BEI_Resources:ARP-153,
BioGRID_ORCS_Cell_line:95,
BioSample:SAMN03471148,
BioSample:SAMN03472333,
BioSample:SAMN10989629,
cancercelllines:CVCL_0030,
CCLV:CCLV-RIE 0082,
CCRID:1101HUM-PUMC000011,
CCRID:1101HUM-PUMC000332,
CCRID:1102HUM-NIFDC00057,
CCRID:3101HUMSCSP504,
CCRID:3101HUMTCHu187,
CCRID:4201HUM-CCTCC00009,
CCRID:5301HUM-KCB90024YJ,
CCTCC:GDC0009,
Cell_Model_Passport:SIDM00846,
ChEMBL-Cells:CHEMBL3308376,
ChEMBL-Targets:CHEMBL399,
CLS:300194,
Cosmic:760219,
Cosmic:760490,
Cosmic:801357,
Cosmic:809231,
Cosmic:877477,
Cosmic:911999,
Cosmic:925354,
Cosmic:928907,
Cosmic:944113,
Cosmic:1019309,
Cosmic:1057766,
Cosmic:1071911,
Cosmic:1131525,
Cosmic:1193029,
Cosmic:1201779,
Cosmic:1324208,
Cosmic:1336880,
Cosmic:1571796,
Cosmic:2301539,
Cosmic:2660190,
Cosmic:2750874,
Cosmic:2791019,
Cosmic:2816214,
Cosmic-CLP:1298134,
dbGAP:phs000640.v4.p1,
DepMap:ACH-001086,
DSMZ:ACC-57,
DSMZCellDive:ACC-57,
ECACC:93021013,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:phs000640,
FCS-free:44-2-47-1-8-9,
GDSC:1298134,
GEO:GSM113863,
GEO:GSM226739,
GEO:GSM226875,
GEO:GSM253298,
GEO:GSM436128,
GEO:GSM436129,
GEO:GSM501788,
GEO:GSM722574,
GEO:GSM722575,
GEO:GSM723055,
GEO:GSM723056,
GEO:GSM1088663,
GEO:GSM1088664,
GEO:GSM1088665,
GEO:GSM1088666,
GEO:GSM1374528,
GEO:GSM1669875,
GEO:GSM1881473,
GEO:GSM1881474,
GEO:GSM1881475,
GEO:GSM7701367,
GEO:GSM7701368,
Hysigen:TCH-C193,
ICLC:HTL95023,
IGRhCellID:HeLA,
IZSLER:BS TCL 20,
JCRB:JCRB9004,
KCB:KCB 86019YJ,
KCB:KCB 90024YJ,
KCLB:10002,
LINCS_HMS:50061,
LINCS_LDP:LCL-1512,
Lonza:51,
MeSH:D006367,
NCBI_Iran:C115,
PharmacoDB:HeLa_536_2019,
PRIDE:PRD000007,
PRIDE:PRD000032,
PRIDE:PRD000123,
PRIDE:PRD000124,
PRIDE:PRD000345,
PRIDE:PRD000376,
PRIDE:PRD000525,
PRIDE:PRD000526,
PRIDE:PRD000527,
PRIDE:PXD000013,
PRIDE:PXD000243,
PRIDE:PXD000252,
PRIDE:PXD000279,
PRIDE:PXD000396,
PRIDE:PXD000474,
PRIDE:PXD000589,
PRIDE:PXD000661,
PRIDE:PXD000680,
PRIDE:PXD000759,
PRIDE:PXD000883,
PRIDE:PXD000895,
PRIDE:PXD000900,
PRIDE:PXD000953,
PRIDE:PXD000954,
PRIDE:PXD000999,
PRIDE:PXD001047,
PRIDE:PXD001118,
PRIDE:PXD001154,
PRIDE:PXD001175,
PRIDE:PXD001249,
PRIDE:PXD001258,
PRIDE:PXD001259,
PRIDE:PXD001278,
PRIDE:PXD001305,
PRIDE:PXD001374,
PRIDE:PXD001381,
PRIDE:PXD001396,
PRIDE:PXD001441,
PRIDE:PXD001541,
PRIDE:PXD001548,
PRIDE:PXD001574,
PRIDE:PXD001660,
PRIDE:PXD001781,
PRIDE:PXD001798,
PRIDE:PXD001805,
PRIDE:PXD001806,
PRIDE:PXD001810,
PRIDE:PXD001863,
PRIDE:PXD001907,
PRIDE:PXD002001,
PRIDE:PXD002039,
PRIDE:PXD002066,
PRIDE:PXD002252,
PRIDE:PXD002277,
PRIDE:PXD002378,
PRIDE:PXD002383,
PRIDE:PXD002395,
PRIDE:PXD002572,
PRIDE:PXD002591,
PRIDE:PXD002704,
PRIDE:PXD002844,
PRIDE:PXD002880,
PRIDE:PXD003186,
PRIDE:PXD003209,
PRIDE:PXD003258,
PRIDE:PXD003370,
PRIDE:PXD003503,
PRIDE:PXD003530,
PRIDE:PXD003560,
PRIDE:PXD003792,
PRIDE:PXD003813,
PRIDE:PXD003909,
PRIDE:PXD003913,
PRIDE:PXD003917,
PRIDE:PXD003924,
PRIDE:PXD004182,
PRIDE:PXD004271,
PRIDE:PXD004273,
PRIDE:PXD004452,
PRIDE:PXD004613,
PRIDE:PXD004736,
PRIDE:PXD004900,
PRIDE:PXD004914,
PRIDE:PXD004933,
PRIDE:PXD004934,
PRIDE:PXD004940,
PRIDE:PXD004995,
PRIDE:PXD005018,
PRIDE:PXD005107,
PRIDE:PXD005181,
PRIDE:PXD005346,
PRIDE:PXD005349,
PRIDE:PXD005366,
PRIDE:PXD005466,
PRIDE:PXD005509,
PRIDE:PXD005572,
PRIDE:PXD005712,
PRIDE:PXD005955,
PRIDE:PXD006112,
PRIDE:PXD006293,
PRIDE:PXD012045,
PRIDE:PXD012188,
PRIDE:PXD013064,
PRIDE:PXD023271,
PRIDE:PXD023835,
PRIDE:PXD027504,
PRIDE:PXD029773,
PRIDE:PXD030304,
Progenetix:CVCL_0030,
PubChem_Cell_line:CVCL_0030,
RCB:RCB0007,
RCB:RCB3680,
SKY/M-FISH/CGH:5351,
TKG:TKG 0331,
TOKU-E:1434,
Ubigene:YC-A012,
Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-08-29 05:16:11 |
39236 |
HK-2 [Human kidney]
Resource Report
Resource Website
1000+ mentions
|
CCTCC Cat# GDC0152, RRID:CVCL_0302
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8127021
PMID:20215515
PMID:20555413
PMID:22949125
PMID:28489074
PMID:30894373
PMID:31068700
PMID:33122286
|
Transformed cell line
|
Male |
Hk-2, HK2, Human Kidney-2 |
CCTCC |
GDC0152 |
BTO:BTO_0003575,
CLO:CLO_0003771,
EFO:EFO_0022529,
MCCL:MCC:0000193,
AddexBio:T0011004/4929,
ATCC:CRL-2190,
BCRC:60097,
BioGRID_ORCS_Cell_line:1711,
BioSample:SAMN03472562,
cancercelllines:CVCL_0302,
CCRID:3101HUMSCSP511,
CCRID:4201HUM-CCTCC00152,
CCTCC:GDC0152,
Cell_Model_Passport:SIDM01818,
ChEMBL-Cells:CHEMBL4295396,
ChEMBL-Targets:CHEMBL4296428,
CLS:305021,
Cosmic:2520628,
DepMap:ACH-001087,
ENCODE:ENCBS188NWH,
GEO:GSM827261,
GEO:GSM4009069,
GEO:GSM4009073,
KCB:KCB 200815YJ,
KCLB:22190,
Lonza:769,
PharmacoDB:HK2_545_2019,
Progenetix:CVCL_0302,
PubChem_Cell_line:CVCL_0302,
Ubigene:YC-C140,
Wikidata:Q54889732 |
|
|
CVCL_0302 |
2026-08-29 05:16:13 |
1900 |
HK-2 [Human kidney]
Resource Report
Resource Website
1000+ mentions
|
KCLB Cat# 22190, RRID:CVCL_0302
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8127021
PMID:20215515
PMID:20555413
PMID:22949125
PMID:28489074
PMID:30894373
PMID:31068700
PMID:33122286
|
Transformed cell line
|
Male |
Hk-2, HK2, Human Kidney-2 |
KCLB |
22190 |
BTO:BTO_0003575,
CLO:CLO_0003771,
EFO:EFO_0022529,
MCCL:MCC:0000193,
AddexBio:T0011004/4929,
ATCC:CRL-2190,
BCRC:60097,
BioGRID_ORCS_Cell_line:1711,
BioSample:SAMN03472562,
cancercelllines:CVCL_0302,
CCRID:3101HUMSCSP511,
CCRID:4201HUM-CCTCC00152,
CCTCC:GDC0152,
Cell_Model_Passport:SIDM01818,
ChEMBL-Cells:CHEMBL4295396,
ChEMBL-Targets:CHEMBL4296428,
CLS:305021,
Cosmic:2520628,
DepMap:ACH-001087,
ENCODE:ENCBS188NWH,
GEO:GSM827261,
GEO:GSM4009069,
GEO:GSM4009073,
KCB:KCB 200815YJ,
KCLB:22190,
Lonza:769,
PharmacoDB:HK2_545_2019,
Progenetix:CVCL_0302,
PubChem_Cell_line:CVCL_0302,
Ubigene:YC-C140,
Wikidata:Q54889732 |
|
|
CVCL_0302 |
2026-08-29 05:16:13 |
1900 |
HK-2 [Human kidney]
Resource Report
Resource Website
1000+ mentions
|
ATCC Cat# CRL-2190, RRID:CVCL_0302
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8127021
PMID:20215515
PMID:20555413
PMID:22949125
PMID:28489074
PMID:30894373
PMID:31068700
PMID:33122286
|
Transformed cell line
|
Male |
Hk-2, HK2, Human Kidney-2 |
ATCC |
CRL-2190 |
BTO:BTO_0003575,
CLO:CLO_0003771,
EFO:EFO_0022529,
MCCL:MCC:0000193,
AddexBio:T0011004/4929,
ATCC:CRL-2190,
BCRC:60097,
BioGRID_ORCS_Cell_line:1711,
BioSample:SAMN03472562,
cancercelllines:CVCL_0302,
CCRID:3101HUMSCSP511,
CCRID:4201HUM-CCTCC00152,
CCTCC:GDC0152,
Cell_Model_Passport:SIDM01818,
ChEMBL-Cells:CHEMBL4295396,
ChEMBL-Targets:CHEMBL4296428,
CLS:305021,
Cosmic:2520628,
DepMap:ACH-001087,
ENCODE:ENCBS188NWH,
GEO:GSM827261,
GEO:GSM4009069,
GEO:GSM4009073,
KCB:KCB 200815YJ,
KCLB:22190,
Lonza:769,
PharmacoDB:HK2_545_2019,
Progenetix:CVCL_0302,
PubChem_Cell_line:CVCL_0302,
Ubigene:YC-C140,
Wikidata:Q54889732 |
|
|
CVCL_0302 |
2026-08-29 05:16:11 |
1900 |
HK-2 [Human kidney]
Resource Report
Resource Website
1000+ mentions
|
Ubigene Cat# YC-C140, RRID:CVCL_0302
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8127021
PMID:20215515
PMID:20555413
PMID:22949125
PMID:28489074
PMID:30894373
PMID:31068700
PMID:33122286
|
Transformed cell line
|
Male |
Hk-2, HK2, Human Kidney-2 |
Ubigene |
YC-C140 |
BTO:BTO_0003575,
CLO:CLO_0003771,
EFO:EFO_0022529,
MCCL:MCC:0000193,
AddexBio:T0011004/4929,
ATCC:CRL-2190,
BCRC:60097,
BioGRID_ORCS_Cell_line:1711,
BioSample:SAMN03472562,
cancercelllines:CVCL_0302,
CCRID:3101HUMSCSP511,
CCRID:4201HUM-CCTCC00152,
CCTCC:GDC0152,
Cell_Model_Passport:SIDM01818,
ChEMBL-Cells:CHEMBL4295396,
ChEMBL-Targets:CHEMBL4296428,
CLS:305021,
Cosmic:2520628,
DepMap:ACH-001087,
ENCODE:ENCBS188NWH,
GEO:GSM827261,
GEO:GSM4009069,
GEO:GSM4009073,
KCB:KCB 200815YJ,
KCLB:22190,
Lonza:769,
PharmacoDB:HK2_545_2019,
Progenetix:CVCL_0302,
PubChem_Cell_line:CVCL_0302,
Ubigene:YC-C140,
Wikidata:Q54889732 |
|
|
CVCL_0302 |
2026-08-29 05:16:11 |
1900 |
AGS
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_0139
|
Homo sapiens (Human)
|
Gastric adenocarcinoma
|
Virology: Persistently infected with parainfluenza virus type 5 (PIV5) strain PIV5-AGS (PubMed=17509637; PubMed=27445371)., Population: Caucasian., Part of: PI3K genetic alteration cell panel (ATCC TCP-1028)., Part of: MD Anderson Cell Lines Project., Part of: JFCR45 cancer cell line panel., Part of: FGFR genetic alteration cell panel (ATCC TCP-1034)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1370612
PMID:6678861
PMID:6831414
PMID:10402490
PMID:15767549
PMID:17509637
PMID:18804159
PMID:20164919
PMID:20215515
PMID:22460905
PMID:24807215
PMID:25485619
PMID:25960936
PMID:25984343
PMID:26589293
PMID:27397505
PMID:27445371
PMID:28196595
PMID:29435981
PMID:29717028
PMID:30894373
PMID:30971826
PMID:31068700
PMID:31978347
PMID:34466148
PMID:35122114
PMID:35839778
|
Cancer cell line
|
Female |
|
|
|
BTO:BTO_0001007,
CLO:CLO_0001686,
EFO:EFO_0002109,
MCCL:MCC:0000032,
CLDB:cl258,
CLDB:cl5134,
AddexBio:C0023004/4958,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-1739,
BCRC:60102,
BCRJ:0311,
BioGRID_ORCS_Cell_line:332,
BioSample:SAMN03471028,
BioSample:SAMN03471416,
BioSample:SAMN10988305,
cancercelllines:CVCL_0139,
CCRID:1101HUM-PUMC000480,
CCRID:3101HUMTCHu232,
CCRID:4201HUM-CCTCC00247,
CCTCC:GDC0247,
Cell_Model_Passport:SIDM00850,
ChEMBL-Cells:CHEMBL3308078,
ChEMBL-Targets:CHEMBL613860,
CLS:300408,
Cosmic:685586,
Cosmic:848149,
Cosmic:868235,
Cosmic:873708,
Cosmic:887255,
Cosmic:888819,
Cosmic:906790,
Cosmic:1067211,
Cosmic:1090463,
Cosmic:1187266,
Cosmic:1294957,
Cosmic:1482073,
Cosmic:1518239,
Cosmic:1582429,
Cosmic:1627261,
Cosmic:1995340,
Cosmic:2036659,
Cosmic:2069770,
Cosmic:2484954,
Cosmic:2823227,
Cosmic-CLP:906790,
DepMap:ACH-000880,
ECACC:89090402,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:EGAS00001002554,
GDSC:906790,
GEO:GSM267417,
GEO:GSM267424,
GEO:GSM267431,
GEO:GSM267438,
GEO:GSM552354,
GEO:GSM562392,
GEO:GSM618009,
GEO:GSM618010,
GEO:GSM618011,
GEO:GSM618012,
GEO:GSM827400,
GEO:GSM828792,
GEO:GSM843440,
GEO:GSM886864,
GEO:GSM887929,
GEO:GSM1237672,
GEO:GSM1237697,
GEO:GSM1250894,
GEO:GSM1250895,
GEO:GSM1250896,
GEO:GSM1250897,
GEO:GSM1374389,
GEO:GSM1374390,
GEO:GSM1669595,
GEO:GSM2983073,
GEO:GSM2983074,
GEO:GSM2983075,
GEO:GSM2983076,
IARC_TP53:21171,
IBRC:C10071,
IGRhCellID:AGS,
IZSLER:BS TCL 135,
KCB:KCB 200708YJ,
KCLB:21739,
LiGeA:CCLE_280,
LINCS_HMS:50004,
LINCS_LDP:LCL-1893,
Lonza:727,
NCBI_Iran:C131,
PharmacoDB:AGS_56_2019,
PRIDE:PXD000722,
PRIDE:PXD030304,
Progenetix:CVCL_0139,
PubChem_Cell_line:CVCL_0139,
TOKU-E:522,
Ubigene:YC-C003,
Wikidata:Q54748713 |
|
|
CVCL_0139 |
2026-08-29 05:22:22 |
143 |
AMO1
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1806
|
Homo sapiens (Human)
|
Plasma cell myeloma
|
Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine., Characteristics: Produces IgA kappa., Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8426482
PMID:9738977
PMID:10936422
PMID:11429052
PMID:12886255
PMID:15215163
PMID:17171682
PMID:18700954
PMID:19306352
PMID:21173094
PMID:22460905
PMID:25485619
PMID:25688540
PMID:25877200
PMID:26589293
PMID:27397505
PMID:28196595
PMID:30285677
PMID:30545397
PMID:30894373
PMID:31068700
PMID:32123307
PMID:35839778
|
Cancer cell line
|
Female |
AMo1, AMO-1 |
|
|
CLO:CLO_0037047,
EFO:EFO_0006534,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ArrayExpress:E-TABM-1088,
BioSample:SAMN03472930,
BioSample:SAMN03473529,
BioSample:SAMN10989573,
cancercelllines:CVCL_1806,
CCRID:1101HUM-PUMC000683,
Cell_Model_Passport:SIDM00993,
CGH-DB:9156-4,
ChEMBL-Cells:CHEMBL4523527,
ChEMBL-Targets:CHEMBL4523558,
Cosmic:1483074,
Cosmic:1889514,
Cosmic:2131561,
Cosmic:2391800,
Cosmic:2809758,
Cosmic-CLP:1295741,
DepMap:ACH-000838,
DSMZ:ACC-538,
DSMZCellDive:ACC-538,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:1295741,
GEO:GSM143353,
GEO:GSM290285,
GEO:GSM562822,
GEO:GSM886868,
GEO:GSM887933,
GEO:GSM1374392,
GEO:GSM1669599,
IARC_TP53:28503,
IBRC:C10685,
LiGeA:CCLE_604,
LINCS_LDP:LCL-1539,
PharmacoDB:AMO1_62_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1806,
PubChem_Cell_line:CVCL_1806,
Wikidata:Q54749810 |
|
|
CVCL_1806 |
2026-08-29 05:22:30 |
15 |
Ishikawa (Heraklio) 02 ER-
Resource Report
Resource Website
Possibly Discontinued
|
ECACC Cat# 98032302, RRID:CVCL_6543
|
Homo sapiens (Human)
|
Type I endometrial adenocarcinoma
|
Population: Japanese., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Probably misclassified/misidentified. ECACC has discontinued this cell line because it displays STR profile from HEC-50B cells (CVCL_2929)..
|
PMID:20215515
PMID:22460905
PMID:30894373
PMID:31068700
PMID:31978347
|
Cancer cell line
|
Female |
Ishikawa(Heraklio)02ER-, ISHIKAWAHERAKLIO02ER, ER-02 ISH |
ECACC |
98032302 |
CLO:CLO_0006967,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN10988025,
cancercelllines:CVCL_6543,
Cell_Model_Passport:SIDM00037,
ECACC:98032302,
EGA:EGAS00001000978,
GDSC:1240156,
GEO:GSM827371,
GEO:GSM887164,
GEO:GSM888236,
IARC_TP53:28398,
LiGeA:CCLE_241,
LINCS_HMS:50019,
LINCS_LDP:LCL-1498,
PharmacoDB:Ishikawa_Heraklio_02ER_668_2019,
Progenetix:CVCL_6543,
Wikidata:Q54898302 |
cvcl_2529 |
|
CVCL_6543 |
2026-08-29 05:29:12 |
0 |
BC-3C
Resource Report
Resource Website
|
RRID:CVCL_1958
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9794224
PMID:22460905
PMID:24035680
PMID:24367658
PMID:29732388
PMID:30894373
PMID:31068700
|
Cancer cell line
|
Female |
BC3c |
|
|
CLO:CLO_0001893,
ArrayExpress:E-MTAB-2770,
BioGRID_ORCS_Cell_line:506,
BioSample:SAMN03473550,
BioSample:SAMN10988581,
cancercelllines:CVCL_1958,
Cell_Model_Passport:SIDM01523,
Cosmic:1046690,
Cosmic:1285112,
Cosmic:1286004,
Cosmic:2050437,
Cosmic:2057442,
Cosmic:2444240,
Cosmic:2685938,
DepMap:ACH-000593,
DSMZ:ACC-450,
DSMZCellDive:ACC-450,
GEO:GSM886873,
GEO:GSM887938,
IARC_TP53:30018,
LiGeA:CCLE_276,
PharmacoDB:BC3C_80_2019,
Progenetix:CVCL_1958,
Wikidata:Q54795193 |
|
|
CVCL_1958 |
2026-08-29 05:26:17 |
0 |
BDCM
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_4613
|
Homo sapiens (Human)
|
Acute myeloid leukemia
|
Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:12437665
PMID:20215515
PMID:22460905
PMID:30285677
PMID:30894373
PMID:31068700
|
Cancer cell line
|
Male |
B-cell with DC Morphology |
|
|
CLO:CLO_0001910,
EFO:EFO_0002113,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2770,
ATCC:CRL-2740,
BioSample:SAMN03471781,
BioSample:SAMN10988332,
cancercelllines:CVCL_4613,
Cell_Model_Passport:SIDM01522,
DepMap:ACH-000080,
GEO:GSM886876,
GEO:GSM887941,
IARC_TP53:30019,
IGRhCellID:BDCM,
LiGeA:CCLE_759,
LINCS_LDP:LCL-1049,
PharmacoDB:BDCM_83_2019,
Progenetix:CVCL_4613,
Wikidata:Q54795803 |
|
|
CVCL_4613 |
2026-08-29 05:26:22 |
1 |
AsPC-1
Resource Report
Resource Website
500+ mentions
|
RRID:CVCL_0152
|
Homo sapiens (Human)
|
Pancreatic ductal adenocarcinoma
|
Caution: TP53 mutation indicated incorrectly as being at c.818G>A in PubMed=1630814., Population: Caucasian., Part of: NCI RAS program mutant KRAS cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1630814
PMID:1764370
PMID:4023565
PMID:6582512
PMID:7182348
PMID:7972006
PMID:8026879
PMID:8194712
PMID:8286197
PMID:9331070
PMID:9665481
PMID:10027410
PMID:10408907
PMID:11115575
PMID:11169959
PMID:11787853
PMID:12692724
PMID:14695172
PMID:15126341
PMID:15367885
PMID:15688027
PMID:15770730
PMID:16912165
PMID:18298655
PMID:18380791
PMID:20037478
PMID:20164919
PMID:20215515
PMID:20418756
PMID:21607521
PMID:22460905
PMID:22585861
PMID:25167228
PMID:25485619
PMID:25877200
PMID:25984343
PMID:26216984
PMID:26586397
PMID:26589293
PMID:27259358
PMID:27397505
PMID:27910856
PMID:28196595
PMID:29444439
PMID:30894373
PMID:30971826
PMID:31068700
PMID:31978347
PMID:32782605
PMID:35839778
|
Cancer cell line
|
Female |
AsPc-1, Aspc-1, ASPC-1, As-PC1, ASPC1, AsPC1, Aspc1, AsPc1 |
|
|
BTO:BTO_0001864,
CLO:CLO_0001756,
EFO:EFO_0002112,
MCCL:MCC:0000044,
CLDB:cl289,
AddexBio:C0018023/5061,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-1682,
BCRC:60494,
BioGRID_ORCS_Cell_line:259,
BioSample:SAMN03471961,
BioSample:SAMN10988235,
cancercelllines:CVCL_0152,
CCRID:1101HUM-PUMC000214,
CCRID:3101HUMTCHu8,
Cell_Model_Passport:SIDM00899,
CGH-DB:160-1,
CGH-DB:9271-4,
ChEMBL-Cells:CHEMBL3307994,
ChEMBL-Targets:CHEMBL612588,
CLS:300158,
Cosmic:707247,
Cosmic:710851,
Cosmic:724645,
Cosmic:808166,
Cosmic:868239,
Cosmic:872994,
Cosmic:910702,
Cosmic:913308,
Cosmic:918050,
Cosmic:922255,
Cosmic:923164,
Cosmic:932514,
Cosmic:933515,
Cosmic:947398,
Cosmic:948371,
Cosmic:948740,
Cosmic:949230,
Cosmic:1006364,
Cosmic:1090374,
Cosmic:1108341,
Cosmic:1198210,
Cosmic:1320465,
Cosmic:1366285,
Cosmic:1477433,
Cosmic:1571783,
Cosmic:1644318,
Cosmic:1995341,
Cosmic:2434085,
Cosmic:2668289,
Cosmic-CLP:910702,
DepMap:ACH-000222,
ECACC:96020930,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:910702,
GEO:GSM206446,
GEO:GSM383935,
GEO:GSM495808,
GEO:GSM621911,
GEO:GSM784702,
GEO:GSM886870,
GEO:GSM887935,
GEO:GSM1024396,
GEO:GSM1177959,
GEO:GSM1177960,
GEO:GSM1177961,
GEO:GSM1374394,
GEO:GSM1374395,
GEO:GSM1374396,
GEO:GSM1588607,
GEO:GSM1588619,
GEO:GSM1669603,
GEO:GSM1906985,
GEO:GSM1906986,
GEO:GSM1906987,
IARC_TP53:311,
IARC_TP53:21127,
IBRC:C10154,
IGRhCellID:AsPC1,
IZSLER:BS TCL 171,
KCLB:21682,
LiGeA:CCLE_008,
LINCS_LDP:LCL-1730,
NCBI_Iran:C558,
PharmacoDB:AsPC1_67_2019,
PRIDE:PXD003198,
PRIDE:PXD030304,
PRIDE:PXD032263,
Progenetix:CVCL_0152,
PubChem_Cell_line:CVCL_0152,
SKY/M-FISH/CGH:1997,
Wikidata:Q54750736 |
|
|
CVCL_0152 |
2026-08-29 05:22:40 |
894 |
B-CPAP
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_0153
|
Homo sapiens (Human)
|
Poorly differentiated thyroid gland carcinoma
|
Caution: Originally classified a thyroid gland papillary carcinoma (PTC) but is now considered to be a poorly differentiated thyroid gland carcinoma (PDTC) (PubMed=23162534)., Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1297527
PMID:8156527
PMID:11439348
PMID:14522906
PMID:15172756
PMID:17725429
PMID:17804723
PMID:18713817
PMID:19087340
PMID:20164919
PMID:21868764
PMID:22087789
PMID:22460905
PMID:23162534
PMID:23833040
PMID:25877200
PMID:26589293
PMID:27397505
PMID:28775782
PMID:30737244
PMID:30894373
PMID:31068700
PMID:31395879
PMID:32666385
PMID:35839778
|
Cancer cell line
|
Female |
BC-PAP, BCPAP |
|
|
BTO:BTO_0004736,
CLO:CLO_0001906,
MCCL:MCC:0000045,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03471001,
BioSample:SAMN10989558,
cancercelllines:CVCL_0153,
CCRID:3101HUMSCSP543,
Cell_Model_Passport:SIDM00992,
ChEMBL-Cells:CHEMBL3308356,
ChEMBL-Targets:CHEMBL1075394,
CLS:305081,
Cosmic:755292,
Cosmic:849970,
Cosmic:924104,
Cosmic:928836,
Cosmic:931241,
Cosmic:1084279,
Cosmic:1162847,
Cosmic:1237447,
Cosmic:1239965,
Cosmic:1280047,
Cosmic:1507369,
Cosmic:1533552,
Cosmic:1536122,
Cosmic:1889007,
Cosmic:2036692,
Cosmic:2054086,
Cosmic:2319847,
Cosmic:2613253,
Cosmic:2791089,
Cosmic-CLP:924104,
DepMap:ACH-000456,
DSMZ:ACC-273,
DSMZCellDive:ACC-273,
EGA:EGAS00001000978,
GDSC:924104,
GEO:GSM886875,
GEO:GSM887940,
GEO:GSM1669612,
IARC_TP53:25011,
LiGeA:CCLE_362,
LINCS_LDP:LCL-1687,
NCBI_Iran:C596,
PharmacoDB:BCPAP_82_2019,
PRIDE:PXD030304,
Progenetix:CVCL_0153,
PubChem_Cell_line:CVCL_0153,
Wikidata:Q54752132 |
|
|
CVCL_0153 |
2026-08-29 05:22:58 |
33 |
